• Profile
Close

Linking altered microRNA expression to racial disparities in uterine serous carcinoma

Gynecologic Oncology Dec 01, 2021

Wei JJ, et al. - Uterine serous carcinoma represents a high grade as well as an aggressive type of endometrial malignancy with a characteristic histologic, molecular, and clinical presentation. A better understanding of the basis for the observed racial disparity for uterine cancer outcomes is needed.

  • Uterine serous carcinoma is responsible for 10% of uterine cancers, but 40% of disease death.

  • A 2- to 4-fold higher incidence of aggressive endometrial cancer subtypes, specifically of uterine serous carcinoma, has been noted in African American (AA) women vs non-Hispanic (NH) White women, which could partly explain the worse survival results for uterine cancer in AA females.

  • Known risk factors for poorer cancer outcomes include clinical factors (e.g., obesity, diabetes, hypertension, and age at diagnosis) and socioeconomic conditions.

  • Other likely contributors to the survival disadvantage among AA women include tumor biology, molecular alterations, and other epigenetic features.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay